Wuxi apptec, INC.:1194620 [23-005301]
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00627
- Awardee
-
Xenobiotic Laboratories Inc. UEI K254CMCPAFJ8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $71,740
Award facts
- Opportunity
-
- Assess Cytochrome P450 (CYP450) Enzymes Induction Potential of 2 Test Articles (TA) Solicitation · 75N95023Q00520 · Posted Aug 11, 2023
- Contract value 100% obligated
- $71,740.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Plainsboro Township, NJ 08536, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $13,000 | |
| Original award | $58,740 |
About this award
Xenobiotic Laboratories Inc. Biotesting Division was awarded a $71,740 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to assess the cytochrome P450 (CYP450) enzyme induction potential of two test articles. Performance will take place in Plainsboro Township, New Jersey from August 2023 through March 2024. The award is in response to a solicitation requesting evaluation of the test articles' induction effects on major human CYP450 enzymes to support drug development efforts for mitragynine and its metabolite 7-hydroxymitragynine by the National Center for Advancing Translational Sciences, which seeks to generate innovative methods and technologies to enhance therapeutic development across a wide range of human diseases under the National Institutes of Health's broader medical research mission.
Quick answers
Who was awarded contract 75N95023P00627?
75N95023P00627 was awarded to Xenobiotic Laboratories Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 24, 2023.
How much is contract 75N95023P00627 worth?
The government has obligated $71,740 on 75N95023P00627.
Which agency awarded contract 75N95023P00627?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023P00627, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95023P00627 competed?
The extent of competition for 75N95023P00627 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award